Interspecies SCNT-derived Humanesque Blastocysts
Keywords: HFEA, Chimeras
Since the 1950s, scientists have developed interspecies blastocysts in laboratory settings, but not until the 1990s did proposals emerge to engineer interspecies blastocysts that contained human genetic or cellular material. Even if these embryos were not permitted to mature to fetal stages, their ethical and political status became debated within nations attempting to use them for research. To study cell differentiation and embryonic development and causes of human diseases, interspecies-somatic-cell-nuclear-transfer -derived (iSCNT) humanesque blastocysts provided opportunities for research and therapy development. Such a technology also involved ethical debates.
During the early 1950s, Robert Briggs at the Institute for Cancer Center, which later became Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Thomas Joseph King Jr. at the Lankenau Hospital Research Institute in Philadelphia, Pennsylvania, studied the developmental trajectory and potential of tadpole embryonic cells. Briggs and King developed a technique to transfer the nucleus, which is the organelle that contains nuclear DNA, of one cell into an enucleated cell, or a cell from which the nucleus has been removed. In 1952 the two published their technique in the article "Transplantation of Living Nuclei from Blastula Cells into Enucleated Frogs' Eggs." The two scientists had transplanted the nucleus, and therefore genetic material, of an adult somatic cell or a differentiated cell into an enucleated egg cell for the first time. Briggs and Kind noted that the resultant blastocyst, or the stage of embryonic development characterized by an inner cell mass surrounded by an outer cell layer, developed into a mature organism.
In the following decades, scientists practiced the procedure with varying degrees of success between different species of organisms, including sheep, goats, chicks, quails, cows, and rabbits. However, only in 1998 were human-derived cellular materials first used for interspecies blastocysts. Jose C. Cibelli at the University of Massachusetts in Amherst, Massachusetts, and his team fused the nucleus of human white blood cells with enucleated cow oocytes. They published their results in the article "Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells." Of the fifty-six transplants conducted in their experiment, only one developed to the sixteen to four-hundred cell stage, and then growth terminated.
In November 2006, two research teams in the UK independently submitted applications to the UK Human Embryology and Fertilisation Authority (HFEA) in London, UK, to develop stem cell lines using animal oocytes and human nuclei. Although Cibelli's team had attempted to develop those cells, they did not plan in their 1998 experiment to keep the cell lines alive. The UK research teams included Lyle Armstrong at Newcastle University in Newcastle upon Tyne, UK, and Stephen Minger at King's College in London, UK. In response, the HFEA held a series of consultations, debates, and surveys with the public and with specialists to make an informed and representative decision about how to address research applications to engineer cross-species blastocyst lines.
On October 1, 2007, the HFEA published its report titled "Hybrids and Chimeras: A report on the findings of the consultation," which described its final decisions. The report states that the HFEA found no reason to prohibit the development of blastocysts using human cellular or genetic material as long as the research is necessary, ethical, and adheres to a strict code of practice. In all cases, the report prohibited researchers to grow such embryos to birth. Additionally, the report states that violating those policies will result in imprisonment. Afterwards, Armstrong and Minger synthesized for the first time iSCNT humanesque-blastocysts (ISHBs).
To create ISHBs, the researchers first obtained an egg cell or oocyte from an animal such as a rabbit or a cow. They treated the female animal with a super-ovulation drug, which helps ovaries release more oocytes compared to a typical ovulation cycle. Then, the researchers extracted the oocytes and removed their nuclei with a pipette. Next, the researchers observed the oocytes under ultraviolet light to ensure that they lacked their nuclei. The researchers then inserted the nucleus of a human somatic cell into an enucleated oocyte by placing it in a fusion chamber and stimulating it electrically or chemically, so that the two entities fused together and developmental began.
After several days of development, blastocysts formed. From a blastocyst, the researchers removed the inner cell mass and cultured it, and then they placed it on a layer of feeder cells and supplied the inner cell mass (ICM) with the nutrients required for survival and replication. After a few days, the researchers observed colonies of undifferentiated stem cells.
In normal embryos, stem cells from the ICM are pluripotent, or can develop into many kinds of more specialized cells as the embryo develops. When scientists culture those ICM cells, the cultured cells are also pluripotent. But for cells cultured from the ICMs of ISHBs, researchers by 2015 had yet to establish that they were similarly pluripotent.
With their experiments, Armstrong and Minger inspired many scientists who aimed to explain aging and how diseases develop in the body, and to find therapies to improve human health. Other researchers addressed the ethical issues underlying the use of animals to model human disorders and diseases. Researchers have shown that some organisms, such as rats, lack the complex neural anatomy and psychology found in humans, and they are thus not good models to study some human diseases such as schizophrenia. Some researchers argued that iSCNT humanesque blastocysts may provide new models to study how a particular disease occurs, as well as the genetics of some pathogeneses.
Research on humanesque blastocysts often bypass the need for human oocytes. Obtaining human oocytes sometimes raised ethical issues because the process to obtain them from women typically poses a series of health risks to the donors at multiple stages of the procedure. For instance, to harvest oocytes, a super-ovulation hormone is administered to the woman for several days to release more oocytes than a normal ovulation cycle. These hormones have been linked to adverse effects on the health of the woman, including cancer or personality and mood shifts. The extraction itself poses risks common to other invasive procedures. In addition, some argue that using human oocytes solely for research purposes diminishes the value of human life. Using animal oocytes to create humanesque blastocyst cell cultures bypasses the need to put women at risk in creating stem cell lines for research.
- Beyhan, Zeki, Iager, Amy E., and Cibelli, Jose B. "Interspecies Nuclear Transfer: Implications for Embryonic Stem Cell Biology." Cell Stem Cell 1 (2007): 502–12. http://www.sciencedirect.com/science/article/pii/S1934590907002263 (Accessed June 19, 2017).
- Bonnicksen, Andrea L. Chimeras, Hybrids, and Interspecies Research: Politics and Policymaking. Washington DC: Georgetown University Press, 2009.
- Briggs, Robert, and King, Thomas Joseph. "Transplantation of Living Nuclei from Blastula Cells into Enucleated Frogs' Eggs." Proceedings of the National Academy of Sciences 38 (1952): 455–63. http://www.pnas.org/content/38/5/455.full.pdf (Accessed December 27, 2015).
- Chang, Kyung H., Lim, Jeong M., Kang, Sung K., Lee, Byeong C., Moon, Shin Y., Hwang, Woo S. "Blastocyst formation, karyotype, and mitochondrial DNA of interspecies embryos derived from nuclear transfer of human cord fibroblasts into enucleated bovine oocytes." Fertility and Sterility 80 (2003): 1380–87.
- Chen, Ying, He, Zhi Xu, Liu, Ailian, Wang, Kai, Mao, Wen Wei, Chu, Jian Xin, Lu, Yong, Fang, Zheng Fu, Shi, Ying Tang, Yang, Qing Zhang, Chen, Da Yuan, Wang, Min Kang, Li, Jin Song, Huang, Shao Liang, Kong, Xiang Yin, Shi, Yao Zhou, Wang, Zhi Qiang, Xia, Jia Hui, Long, Zhi Gao, Xue, Zhi Gang, Ding, Wen Xiang, and Sheng, Hui Zhen. "Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes." Cell Research 13 (2003): 251–63. http://www.nature.com/cr/journal/v13/n4/full/7290170a.html (Accessed June 19, 2017).
- Cibelli, Jose B., Stice, Stevem L., Golueke, Paul J., Kane, Jeff J., Jerry, Joseph, Blackwell, Cathy, Ponce de Leon, F. Abel, and Robi, James M. "Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells." Nature Biotechnology 16 (1998): 642–46.
- Di Barardino, Marie. Robert W. Briggs 1911–1983. Washington D.C.: National Academies Press, 1999. http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/briggs-robert-w.pdf (Accessed June 19, 2017).
- Gurdon, John B., and Wilmut, Ian. "Nuclear transfer to eggs and oocytes." Cold Spring Harbor Perspectives Biology 3 (2011): a002659. http://cshperspectives.cshlp.org/content/3/6/a002659.full (Accessed June 19, 2017).
- Human Fertilization and Embryology Authority. "Hybrids and Chimeras: A Consultation on the Ethical and Social Implications of Creating Human/Animal Embryos in Research." London: April, 2007. http://www.hfea.gov.uk/docs/Hybrids_Chimera_review.pdf (Accessed March 2, 2013).
- Human Fertilization and Embryology Authority. "HFEA Review of Hybrids and Chimeras." London: October, 2007. http://www.hfea.gov.uk/519.html (Accessed March 24, 2013).
- Illmensee, Karl, Levanduski, Mike, and Zavos, Panayiotis M. "Evaluation of the embryonic preimplantation potential of human adult somatic cells via an embryo interspecies bioassay using bovine oocytes." Fertility and Sterility 85 (2003): 1248–60.
- Kim, K., A. Doi, B. Wen, K. Ng, R. Zhao, P. Cahan, J. Kim, M.J. Aryee, H. Ji, L.I.R. Ehrlich, A. Yabuuchi, A. Takeuchi, K.C. Cunniff, H. Hongguang, S. McKinney-Freeman, O. Naveiras, T.J. Yoon, R.A. Irizarry, N. Jung, J. Seita, J. Hanna, P. Murakami, R. Jaenisch, R. Weissleder, S.H. Orkin, I.L. Weissman, A.P. Feinberg, and G.Q. Daley. "Epigenetic memory in induced pluripotent stem cells." Nature 467 (2010): 285–90. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150836/ (Accessed June 19, 2017).
- Lanza, Robert P., Cibelli, Jose B., and West, Michael D. "Human therapeutic cloning." Nature Medicine 5 (1999): 975–77.
- Minger, Stephen. "Interspecies SCNT-derived human embryos – a new way forward for regenerative medicine." Regenerative Medicine 2 (2007): 103–06. http://www.futuremedicine.com/doi/full/10.2217/174607220.127.116.11 (Accessed June 19, 2017).
- Narbonne, Patrick, Miyamoto, Kei, and Gurdon, John B. "Reprogramming and development in nuclear transfer embryos and in interspecific systems." Current Opinion in Genetics and Development 22 (2012): 450–58. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654497/ (Accessed June 19, 2017).
- Robert, Jason Scott. "The science and ethics of making part-human animals in stem cell biology." The FASEB Journal 20 (2006): 838–45.
- Soza-Ried, Jorge, and Fisher, Amanda G. "Reprogramming somatic cells towards pluripotency by cellular fusion." Current Opinion in Genetics and Development 22 (2012): 459–65.
- "Thomas J. King (1921–2000)." Society for Developmental Biology. http://www.sdbonline.org/archive/SDBMembership/king-tj-obit.html (Accessed 31 March 2013).
- Williams, Nigel. "UK battle over hybrid stem cells." Current Biology 17 (2007): 297–8. http://www.sciencedirect.com/science/article/pii/S0960982207012468 (Accessed June 19, 2017).